The benefits of magnetic/protein targeted drug delivery in treating skin cancer in-vivo

Loading...
Thumbnail Image
Authors
Misak, Heath Edward
Abedin, Farhana
Man, Michelle
Herring, Jennifer
Issue Date
2011-05-04
Type
Conference paper
Language
en_US
Keywords
Research Projects
Organizational Units
Journal Issue
Alternative Title
Abstract

Skin cancer represents the most common type of cancers, and is life threatening without treatment. People with light skin, genetic diseases and high exposure to ultraviolet radiation (UVR) are at a high risk of developing skin cancer. Skin cancer once developed may spread to the rest of the body including organs inside the body. Once the cancer advances and metastasizes, it is difficult to control and treat. We report on a magnetic carrier system (MCS) that is capable of localizing the chemotherapy at the afflicted area. In-vivo experiments have shown that utilizing the MCS developed at Wichita State University (WSU) the efficacy of the chemotherapy can be enhanced at least twofold.

Description
Fifth place winner of poster presentations at the 7th Annual Symposium on Graduate Research and Scholarly Projects (GRASP) held at the Marcus Welcome Center, Wichita State University, May 4, 2011.
Research completed at the Department of Mechanical Engineering, College of Engineering and Department of Biological Sciences
Citation
Misak, Heath E., Abedin, Farhana, Man, Michelle & Herring, Jennifer (2011). The Benefits of Magnetic/Protein Targeted Drug Delivery in Treating Skin Cancer in-Vivo. -- In Proceedings: 7th Annual Symposium: Graduate Research and Scholarly Projects. Wichita, KS: Wichita State University, p. 103-104
Publisher
Wichita State University. Graduate School
License
Journal
Volume
Issue
PubMed ID
DOI
ISSN
EISSN